| scholarly article | Q13442814 |
| P50 | author | Myung-Haing Cho | Q56452675 |
| P2093 | author name string | Seung Bum Park | |
| Kee Ho Lee | |||
| Sung Jin Park | |||
| Hyun Woo Kim | |||
| Tae-Jong Yoon | |||
| Jun Sung Kim | |||
| Jin-Kyu Lee | |||
| Kyeong Nam Yu | |||
| Byung Gul Kim | |||
| P433 | issue | 1 | |
| P921 | main subject | magnetic nanoparticle | Q117817683 |
| magnetite nanoparticle | Q3870166 | ||
| nanoparticle | Q61231 | ||
| toxicity | Q274160 | ||
| P304 | page(s) | 338-347 | |
| P577 | publication date | 2005-10-19 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | Toxicity and tissue distribution of magnetic nanoparticles in mice | |
| P478 | volume | 89 |
| Q64228842 | A Novel Contrast Agent Based on Magnetic Nanoparticles for Cholesterol Detection as Alzheimer's Disease Biomarker |
| Q33725375 | A comparative study of neurotoxic potential of synthesized polysaccharide-coated and native ferritin-based magnetic nanoparticles. |
| Q38552210 | A perspective on the potential risks of emerging contaminants to human and environmental health. |
| Q28383491 | A review of nanoparticle functionality and toxicity on the central nervous system |
| Q33547198 | A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study |
| Q90399895 | Aptamers Increase Biocompatibility and Reduce the Toxicity of Magnetic Nanoparticles Used in Biomedicine |
| Q34787906 | Assessment of ZnO and SiO2 nanoparticle permeability through and toxicity to the blood-brain barrier using Evans blue and TEM |
| Q34785878 | Bifunctional silica nanoparticles for the exploration of biofilms of Pseudomonas aeruginosa |
| Q37588362 | Bio-active engineered 50 nm silica nanoparticles with bone anabolic activity: therapeutic index, effective concentration, and cytotoxicity profile in vitro |
| Q35637499 | Bioactive silica nanoparticles reverse age-associated bone loss in mice |
| Q58436578 | Bioanalytical strategies for in-vitro and in-vivo evaluation of the toxicity induced by metallic nanoparticles |
| Q57821638 | Biodistribution and Tumors MRI Contrast Enhancement of Magnetic Nanocubes, Nanoclusters, and Nanorods in Multiple Mice Models |
| Q39739008 | Biodistribution and biocompatibility of DMSA-stabilized maghemite magnetic nanoparticles in nonhuman primates (Cebus spp.). |
| Q92666184 | Biodistribution, biocompatibility and targeted accumulation of magnetic nanoporous silica nanoparticles as drug carrier in orthopedics |
| Q33659702 | Biomedical applications of nanotechnology. |
| Q52583559 | Brain Iron Distribution after Multiple Doses of Ultra-small Superparamagnetic Iron Oxide Particles in Rats. |
| Q58549950 | Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG and Pluronic P85 unimers |
| Q37365453 | Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes |
| Q38558102 | Challenges and new strategies for therapeutic peptide delivery to the CNS. |
| Q49438313 | Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles |
| Q36741021 | Converging cognitive enhancements |
| Q59803336 | Cytotoxic and Membrane Cholesterol Effects of Ultraviolet Irradiation and Zinc Oxide Nanoparticles on Chinese Hamster Ovary Cells |
| Q37115126 | Cytotoxicity evaluation of carbon-encapsulated iron nanoparticles in melanoma cells and dermal fibroblasts |
| Q42416610 | DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination |
| Q52647853 | Daily exposure to silver nanoparticles during prepubertal development decreases adult sperm and reproductive parameters. |
| Q57369025 | Deferasirox-coated iron oxide nanoparticles as a potential cytotoxic agent |
| Q48284368 | Designing drug-delivery systems for the nervous system using nanotechnology: opportunities and challenges |
| Q49988367 | Determination of mutagenicity and genotoxicity of indium tin oxide nanoparticles using the Ames test and micronucleus assay |
| Q92637248 | Ecotoxicity Assessment of Fe3O4 Magnetic Nanoparticle Exposure in Adult Zebrafish at an Environmental Pertinent Concentration by Behavioral and Biochemical Testing |
| Q33720402 | Effect of fluorescent silica nanoparticles in embryo and larva of Oryzias latipes: Sonic effect in nanoparticle dispersion |
| Q37091154 | Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells |
| Q46149495 | Effects of zinc oxide nanoparticles and/or zinc chloride on biochemical parameters and mineral levels in rat liver and kidney |
| Q50437119 | Efficacy of Dipeptide-Coated Magnetic Nanoparticles in Lung Cancer Models Under Pulsed Electromagnetic Field. |
| Q39365096 | Efficient transfection of MG-63 osteoblasts using magnetic nanoparticles and oscillating magnetic fields. |
| Q46715643 | Engineered magnetic nanoparticles for biomedical applications |
| Q90328975 | Engineering Iron Oxide Nanoparticles for Clinical Settings |
| Q91705466 | Enhanced anti-tumor immunotherapy by silica-coated magnetic nanoparticles conjugated with ovalbumin |
| Q34163460 | Enhanced uptake of porous silica microparticles by bifunctional surface modification with a targeting antibody and a biocompatible polymer |
| Q57347001 | Epoxide Functional Temperature-Sensitive Semi-IPN Hydrogel Microspheres for Isolating Inorganic Nanoparticles |
| Q38417299 | Evaluation of Iron Oxide Nanoparticles Toxicity on Liver Cells of BALB/c Rats |
| Q34787893 | Evaluation of silica nanoparticle toxicity after topical exposure for 90 days |
| Q58235087 | Exosomes as Extrapulmonary Signaling Conveyors for Nanoparticle-Induced Systemic Immune Activation |
| Q88605247 | Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states |
| Q37935681 | Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. |
| Q27330313 | Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier |
| Q48704117 | Fluorescent dye-doped silica nanoparticles: new tools for bioapplications |
| Q30837679 | Gd-Al co-doped mesoporous silica nanoparticles loaded with Ru(bpy)₃²⁺ as a dual-modality probe for fluorescence and magnetic resonance imaging |
| Q40391312 | Genotoxic effects of chromium oxide nanoparticles and microparticles in Wistar rats after 28 days of repeated oral exposure |
| Q42823196 | Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay. |
| Q37997950 | Genotoxicity investigations on nanomaterials |
| Q90359981 | Genotoxicity of amorphous silica nanoparticles: Status and prospects |
| Q56834620 | Genotoxicity of engineered nanomaterials: A critical review |
| Q35056553 | Gold nanoparticles interfere with sperm functionality by membrane adsorption without penetration. |
| Q39406233 | Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity |
| Q34349734 | Impact of metal nanoparticles on germ cell viability and functionality |
| Q46877268 | Impact of particle size and light exposure on the effects of TiO2 nanoparticles on Caenorhabditis elegans |
| Q60449261 | Impact of silicon-based quantum dots on the antioxidative system in white muscle of Carassius auratus gibelio |
| Q51075805 | Improvement in Spinal Cord Injury-Induced Bladder Fibrosis Using Mesenchymal Stem Cell Transplantation Into the Bladder Wall. |
| Q58035159 | Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide |
| Q26779017 | In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles. |
| Q92941645 | In Vivo Investigation into Effectiveness of Fe₃O₄/PLLA Nanofibers for Bone Tissue Engineering Applications |
| Q57340615 | In VivoNanotoxicity Assays in Animal Models |
| Q28386315 | In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines |
| Q92923829 | In vivo Toxicity Investigation of Magnesium Oxide Nanoparticles in Rat for Environmental and Biomedical Applications |
| Q36289257 | In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles |
| Q33411683 | In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test. |
| Q43261089 | In vivo imaging of sentinel nodes using fluorescent silica nanoparticles in living mice |
| Q28389093 | In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms |
| Q37388332 | In vivo toxicity studies of europium hydroxide nanorods in mice |
| Q36085406 | In vivo tracking of mesechymal stem cells using fluorescent nanoparticles in an osteochondral repair model |
| Q28950523 | Inflammatory response of mice following inhalation exposure to iron and copper nanoparticles |
| Q38813548 | Influence of Nanotoxicity on Human Health and Environment: The Alternative Strategies |
| Q48390882 | Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats |
| Q31171380 | Injection of ligand-free gold and silver nanoparticles into murine embryos does not impact pre-implantation development |
| Q37812005 | Inorganic Nanoparticles in Cancer Therapy |
| Q36977563 | Inorganic/Organic Hybrid Silica Nanoparticles as a Nitric Oxide Delivery Scaffold |
| Q50188813 | Integration of metabolomics and transcriptomics in nanotoxicity studies. |
| Q39042660 | Interaction of differently functionalized fluorescent silica nanoparticles with neural stem- and tissue-type cells |
| Q39596115 | Interaction of spherical silica nanoparticles with neuronal cells: size-dependent toxicity and perturbation of calcium homeostasis |
| Q36365943 | Interfacing Inorganic Nanowire Arrays and Living Cells for Cellular Function Analysis |
| Q37248790 | Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system |
| Q48177260 | Iron Oxide Nanoparticles: Innovative Tool in Cancer Diagnosis and Therapy. |
| Q44683380 | Knowledge gaps in risk assessment of nanosilica in food: evaluation of the dissolution and toxicity of different forms of silica |
| Q38838696 | Label-Free Ferrocene-Loaded Nanocarrier Engineering for In Vivo Cochlear Drug Delivery and Imaging. |
| Q46930588 | Long-term effects of silver nanoparticles on reproductive activity of rabbit buck. |
| Q42229232 | Magnetic Hyperthermia and Oxidative Damage to DNA of Human Hepatocarcinoma Cells |
| Q34667806 | Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study. |
| Q38831669 | Magnetic nanoparticle-mediated hyperthermia therapy induces tumour growth inhibition by apoptosis and Hsp90/AKT modulation. |
| Q36177729 | Magnetic nanoparticles as targeted delivery systems in oncology |
| Q28389421 | Magnetic nanoparticles for theragnostics |
| Q37955034 | Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects. |
| Q28247202 | Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects |
| Q39432174 | Magnetite induces oxidative stress and apoptosis in lung epithelial cells |
| Q33829616 | Manipulation of isolated brain nerve terminals by an external magnetic field using D-mannose-coated γ-Fe2O3 nano-sized particles and assessment of their effects on glutamate transport. |
| Q34321828 | Manufacture of IRDye800CW-coupled Fe3O4 nanoparticles and their applications in cell labeling and in vivo imaging |
| Q90119527 | Mechanism of cell death induced by silica nanoparticles in hepatocyte cells is by apoptosis |
| Q38078983 | Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles |
| Q35731259 | Metabolic and structural integrity of magnetic nanoparticle-loaded primary endothelial cells for targeted cell therapy |
| Q38984552 | Metabolomic profiles delineate the potential role of glycine in gold nanorod-induced disruption of mitochondria and blood-testis barrier factors in TM-4 cells |
| Q28396375 | Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications |
| Q38097386 | Metal-based nanoparticle interactions with the nervous system: the challenge of brain entry and the risk of retention in the organism |
| Q34129403 | Metal‐based nanoparticles and their toxicity assessment |
| Q43874910 | Microstructure, mechanical property, biodegradation behavior, and biocompatibility of biodegradable Fe-Fe2O3 composites. |
| Q64993750 | Mitochondrial impairment and oxidative stress mediated apoptosis induced by α-Fe2O3 nanoparticles in Saccharomyces cerevisiae. |
| Q47097006 | Molecular Mechanisms of Zinc Oxide Nanoparticle-Induced Genotoxicity Short Running Title: Genotoxicity of ZnO NPs. |
| Q27308522 | Movement of magnetic nanoparticles in brain tissue: mechanisms and impact on normal neuronal function |
| Q26827999 | Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency |
| Q38624223 | Nanomagnetic Gene Transfection for Non-Viral Gene Delivery in NIH 3T3 Mouse Embryonic Fibroblasts. |
| Q38334868 | Nanomaterials and neurodegeneration. |
| Q38665015 | Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer |
| Q37988213 | Nanomedicine and veterinary science: the reality and the practicality |
| Q36643024 | Nanomedicine: An unresolved regulatory issue |
| Q29615628 | Nanoparticle therapeutics: an emerging treatment modality for cancer |
| Q36889441 | Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology |
| Q37999461 | Nanoparticles and spermatogenesis: how do nanoparticles affect spermatogenesis and penetrate the blood-testis barrier |
| Q57340468 | Nanoparticles as a Smart Technology for Remediation |
| Q30446788 | Nanoparticles in sentinel lymph node assessment in breast cancer |
| Q28727602 | Nanoparticles in the environment: assessment using the causal diagram approach |
| Q23909949 | Nanoparticulates |
| Q58909862 | Nanostructures for Medical Diagnostics |
| Q37948993 | Nanotherapeutics for Alzheimer's disease (AD): Past, present and future |
| Q23909944 | Nanotoxicology - a pathologist's perspective |
| Q33887120 | New method to prepare very stable and biocompatible fluorescent silica nanoparticles |
| Q45104981 | No evidence of the genotoxic potential of gold, silver, zinc oxide and titanium dioxide nanoparticles in the SOS chromotest |
| Q37131939 | Nonporous Silica Nanoparticles for Nanomedicine Application. |
| Q47893480 | Oscillating magnet array-based nanomagnetic gene transfection of human mesenchymal stem cells. |
| Q38680244 | Osmotin-loaded magnetic nanoparticles with electromagnetic guidance for the treatment of Alzheimer's disease. |
| Q40873998 | Oxidative stress response in neural stem cells exposed to different superparamagnetic iron oxide nanoparticles |
| Q36677492 | Oxidative stress, inflammation, and DNA damage in multiple organs of mice acutely exposed to amorphous silica nanoparticles |
| Q26746918 | Perspective of Fe3O4 Nanoparticles Role in Biomedical Applications. |
| Q38197488 | Perturbation of physiological systems by nanoparticles. |
| Q38260360 | Pharmacokinetics of metallic nanoparticles. |
| Q51613858 | Phenytoin carried by silica core iron oxide nanoparticles reduces the expression of pharmacoresistant seizures in rats. |
| Q60303362 | Potential adverse effects of nanoparticles on the reproductive system |
| Q26744195 | Potential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: treatment strategies and anticipated applications of nanoparticles in gene delivery |
| Q28393651 | Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION) |
| Q30657936 | Predictive toxicology of cobalt ferrite nanoparticles: comparative in-vitro study of different cellular models using methods of knowledge discovery from data |
| Q38820089 | Preliminary study of injury from heating systemically delivered, nontargeted dextran-superparamagnetic iron oxide nanoparticles in mice. |
| Q57176306 | Recent Progress in Metal-Based Nanoparticles Mediated Photodynamic Therapy |
| Q39909193 | Repeated exposure to iron oxide nanoparticles causes testicular toxicity in mice. |
| Q34468073 | Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review |
| Q34005745 | Signaling pathways in spermatogonial stem cells and their disruption by toxicants |
| Q38269215 | Silica-based nanoparticles: a versatile tool for the development of efficient imaging agents. |
| Q37063954 | Silica-coated magnetic nanoparticles impair proteasome activity and increase the formation of cytoplasmic inclusion bodies in vitro |
| Q34000813 | Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cells. |
| Q47424149 | Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice |
| Q35234739 | Size-dependent in vivo toxicity of PEG-coated gold nanoparticles |
| Q39761621 | Stimuli-Regulated Enzymatically Degradable Smart Graphene-Oxide-Polymer Nanocarrier Facilitating Photothermal Gene Delivery |
| Q36202455 | Structural and oxidative changes in the kidney of crucian carp induced by silicon-based quantum dots |
| Q30393869 | Sub-acute intravenous administration of silver nanoparticles in male mice alters Leydig cell function and testosterone levels. |
| Q41923928 | Testicular biodistribution of 450 nm fluorescent latex particles after intramuscular injection in mice. |
| Q28385555 | The nanosilica hazard: another variable entity |
| Q57192248 | Therapeutic activity of sour orange albedo extract and abundant flavanones loaded silica nanoparticles against acrylamide-induced hepatotoxicity |
| Q57129968 | Tissue Morphology and Gene Expression Characterisation of Transplantable Adenocarcinoma Bearing Mice Exposed to Fluorodeoxyglucose-Conjugated Magnetic Nanoparticles |
| Q30394819 | Toxicity assessment of iron oxide nanoparticles in zebrafish (Danio rerio) early life stages |
| Q41453466 | Toxicity of Nanoparticles on the Reproductive System in Animal Models: A Review |
| Q49993811 | Toxicity of PEG-Coated CoFe2O4 Nanoparticles with Treatment Effect of Curcumin |
| Q37858903 | Toxicity of nanocrystal quantum dots: the relevance of surface modifications |
| Q28383168 | Toxicity of nanomaterials |
| Q34231174 | Toxicologic effects of gold nanoparticles in vivo by different administration routes |
| Q35946850 | Toxicological effect of TiO2 nanoparticle-induced myocarditis in mice |
| Q38072037 | Toxicology and clinical potential of nanoparticles |
| Q28393315 | Toxicology of antimicrobial nanoparticles for prosthetic devices |
| Q26785642 | Tracking Transplanted Stem Cells Using Magnetic Resonance Imaging and the Nanoparticle Labeling Method in Urology |
| Q42955563 | Tracking of transplanted mesenchymal stem cells labeled with fluorescent magnetic nanoparticle in liver cirrhosis rat model with 3-T MRI |
| Q47996128 | Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier |
| Q34231144 | Treatment of human astrocytoma U87 cells with silicon dioxide nanoparticles lowers their survival and alters their expression of mitochondrial and cell signaling proteins |
| Q41448619 | Uptake and bio-reactivity of polystyrene nanoparticles is affected by surface modifications, ageing and LPS adsorption: in vitro studies on neural tissue cells. |
| Q30835947 | Uptake and metabolism of iron oxide nanoparticles in brain cells. |
| Q54240716 | Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma. |
| Q36936772 | Use of fluorescent quantum dot bioconjugates for cellular imaging of immune cells, cell organelle labeling, and nanomedicine: surface modification regulates biological function, including cytotoxicity |
| Q28654659 | When neurons encounter nanoobjects: spotlight on calcium signalling |
| Q57344890 | γ-Fe2O3 Nanoparticles Covered with Glutathione-Modified Quantum Dots as a Fluorescent Nanotransporter |
Search more.